Early to Mid-Stage Biotechs: Creating Partnerships to Enhance Program Value and Accelerate Therapies

Moderated by Drew Armstrong of Endpoints News, this interactive panel discussion aimed at early to mid stage biotechs features key industry heavyweights as they share their insights and experience building foundational relationships in support of their programs and mission.